FDA Approves Recombinant Porcine-Sequence Factor VIII
Fri, 24 Oct 2014 00:00:00 -0400
FDA on October 23 approved recombinant porcine-sequence antihemophilic factor, or Obizur, for the treatment of bleeding episodes in adults with acquired hemophilia A.
Hospira Recalls Dozens of Product Lots
Thu, 23 Oct 2014 00:00:00 -0400
Hospira recently announced the recall of one lot of lidocaine hydrochloride injection (PDF) and multiple lots of 12 injectable products packaged in flexible i.v. containers (PDF) .
Worldwide Pharmacy Meeting Discusses Future of Hospital Practice, Ethics
More than 1900 pharmacists and pharmaceutical scientists from 95 countries gathered in Bangkok, Thailand, from August 31 to September 4 for the 74th annual World Congress of Pharmacy and Pharmaceutical Sciences.
FDA, Advisers Mull "Polypill" for Patients With Cardiovascular Disease
Wed, 22 Oct 2014 00:00:00 -0400
concept of combination therapy packaged in a so-called polypill for patients
with cardiovascular disease received a mostly favorable reception in September
from FDA officials and agency advisers.
Nintedanib Approved as Idiopathic Pulmonary Fibrosis Treatment
Mon, 20 Oct 2014 00:00:00 -0400
FDA last week approved the marketing of nintedanib, or Ofev, for the treatment of idiopathic pulmonary fibrosis.